Downloads provided by UsageCounts
handle: 10261/233157
One inhibitor of the fatty acid transporter FATP4 was synthesized in a three steps one-pot process in the presence of a bifunctional metal/acid catalyst. This molecule which has potential interest for the treatment of the obesity in orlistat (Xenical TM) analogue-based therapies has a 3,4-dihydropyrimidin-2(1H)-one (DHPM) scaffold and was obtained by means of a three one-pot process through successive oxidation, cyclocondensation and transesterification reactions. The one-pot strategy was extended to the synthesis of a series of related ester DHPM derivatives.
Financial support by the Ministerio de Economia y Competitividad, Programa Severo Ochoa (SEV2016-0683) and Ministerio de Ciencia Innovacion y Universidades, Programa Estatal de Generación de Conocimiento (PGC2018-101247-B-100) are gratefully acknowledged.
Dihydropyrimidinone, QUIMICA ORGANICA, Pharmaceuticals, One-pot, synthesis, Catalyst, Bifunctional
Dihydropyrimidinone, QUIMICA ORGANICA, Pharmaceuticals, One-pot, synthesis, Catalyst, Bifunctional
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 132 | |
| downloads | 319 |

Views provided by UsageCounts
Downloads provided by UsageCounts